Figma's rapid ascent hasn't gone unnoticed by its larger competitors. In Sept. 2022, Adobe attempted to acquire Figma for $20 ...

A trial led by Kyoto University researchers indicated treatment using induced Pluripotent Stem cells was safe and successful ...

Tokyo: Japanese drugmaker Sumitomo Pharma said Tuesday it is seeking approval for a Parkinson s disease treatment that transplants stem cells into a ...

If there is anything that has defined consumer trends in 2025, it has to be Labubus. Wearing an impish smile and boasting an ...